NCT04956640: Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 540 planned
- Started
- 19 Jul 2021
- Primary completion
- Apr 2027
- Arms
- LY3537982 (Dose Expansion)
- Results
- None posted
- 9 Jul 2021: Trial registered
- 19 Jul 2021: Trial started